|
1
|
Gu L and Sun W: MiR-539 inhibits thyroid
cancer cell migration and invasion by directly targeting CARMA1.
Biochem Biophys Res Commun. 464:1128–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao X, Wu X, Zhang X, Hua W and Zhang Y,
Maimaiti Y, Gao Z and Zhang Y: Inhibition of BRD4 suppresses tumor
growth and enhances iodine uptake in thyroid cancer. Biochem
Biophys Res Commun. 469:679–685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mio C, Lavarone E, Conzatti K, Baldan F,
Toffoletto B, Puppin C, Filetti S, Durante C, Russo D, Orlacchio A,
et al: MCM5 as a target of BET inhibitors in thyroid cancer cells.
Endocr Relat Cancer. 23:335–347. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nicodeme E, Jeffrey KL, Schaefer U, Beinke
S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H,
et al: Suppression of inflammation by a synthetic histone mimic.
Nature. 468:1119–1123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fu LL, Tian M, Li X, Li JJ, Huang J,
Ouyang L, Zhang Y and Liu B: Inhibition of BET bromodomains as a
therapeutic strategy for cancer drug discovery. Oncotarget.
6:5501–5516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng Z, Gong Y, Ma Y, Lu K, Lu X, Pierce
LA, Thompson RC, Muller S, Knapp S and Wang J: Inhibition of BET
bromodomain targets genetically diverse glioblastoma. Clin Cancer
Res. 19:1748–1759. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sahni JM, Gayle SS, Bonk KLW, Vite LC,
Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, et
al: Bromodomain and extraterminal protein inhibition blocks growth
of triple-negative breast cancers through the suppression of aurora
kinases. J Biol Chem. 291:23756–23768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dawson MA, Prinjha RK, Dittmann A,
Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C,
Savitski MM, et al: Inhibition of BET recruitment to chromatin as
an effective treatment for MLL-fusion leukaemia. Nature.
478:529–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Filippakopoulos P, Qi J, Picaud S, Shen Y,
Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et
al: Selective inhibition of BET bromodomains. Nature.
468:1067–1073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Lv B, Chen B, Guan M, Sun Y, Li H,
Zhang B, Ding C, He S and Zeng Q: Inhibition of miR-146b expression
increases radioiodine-sensitivity in poorly differential thyroid
carcinoma via positively regulating NIS expression. Biochem Biophys
Res Commun. 462:314–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fuziwara CS and Kimura ET: MicroRNA
Deregulation in anaplastic thyroid cancer biology. Int J
Endocrinol. 2014:7434502014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Borrelli N, Denaro M, Ugolini C, Poma AM,
Miccoli M, Vitti P, Miccoli P and Basolo F: miRNA expression
profiling of ‘noninvasive follicular thyroid neoplasms with
papillary-like nuclear features’ compared with adenomas and
infiltrative follicular variants of papillary thyroid carcinomas.
Mod Pathol. 30:39–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pilli T, Prasad KV, Jayarama S, Pacini F
and Prabhakar BS: Potential utility and limitations of thyroid
cancer cell lines as models for studying thyroid cancer. Thyroid.
19:1333–1342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schweppe RE, Klopper JP, Korch C,
Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland
JA, Smallridge RC, et al: Deoxyribonucleic acid profiling analysis
of 40 human thyroid cancer cell lines reveals cross-contamination
resulting in cell line redundancy and misidentification. J Clin
Endocrinol Metab. 93:4331–4341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Passon N, Gerometta A, Puppin C, Lavarone
E, Puglisi F, Tell G, Di Loreto C and Damante G: Expression of
Dicer and Drosha in triple-negative breast cancer. J Clin Pathol.
65:320–326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gatfield D, Le Martelot G, Vejnar CE,
Gerlach D, Schaad O, Fleury-Olela F, Ruskeepää AL, Oresic M, Esau
CC, Zdobnov EM, et al: Integration of microRNA miR-122 in hepatic
circadian gene expression. Genes Dev. 23:1313–1326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chowdhari S and Saini N: hsa-miR-4516
mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA
induced apoptosis in keratinocytes. J Cell Physiol. 229:1630–1638.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong W, Cui J, Tian X, He L, Wang Z, Zhang
P and Zhang H: Aberrant sonic hedgehog signaling pathway and STAT3
activation in papillary thyroid cancer. Int J Clin Exp Med.
7:1786–1793. 2014.PubMed/NCBI
|
|
19
|
Yan LI, Li LI, Li Q, Di W, Shen W, Zhang L
and Guo H: Expression of signal transducer and activator of
transcription 3 and its phosphorylated form is significantly
upregulated in patients with papillary thyroid cancer. Exp Ther
Med. 9:2195–2201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Gill A, Atmore B, Johns A,
Delbridge L, Lai R and McMullen T: Upregulation of the signal
transducers and activators of transcription 3 (STAT3) pathway in
lymphatic metastases of papillary thyroid cancer. Int J Clin Exp
Pathol. 4:356–362. 2011.PubMed/NCBI
|
|
21
|
Lee J-J, Lee J-S, Cui MN, Yun HH, Kim HY,
Lee SH and Lee J-H: BIS targeting induces cellular senescence
through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in
glioblastoma cells. Cell Death Dis. 5:e15372014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bochis OV, Irimie A, Pichler M and
Berindan-Neagoe I: The role of Skp2 and its substrate CDKN1B (p27)
in colorectal cancer. J Gastrointestin Liver Dis. 24:225–234.
2015.PubMed/NCBI
|
|
23
|
Sos ML, Levin RS, Gordan JD, Oses-Prieto
JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F,
Bandyopadhyay S, et al: Oncogene mimicry as a mechanism of primary
resistance to BRAF inhibitors. Cell Reports. 8:1037–1048. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wójcicka A, Kolanowska M and Jażdżewski K:
Mechanisms in endocrinology: MicroRNA in diagnostics and therapy of
thyroid cancer. Eur J Endocrinol. 174:R89–R98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leonardi GC, Candido S, Carbone M,
Colaianni V, Garozzo SF, Cinà D and Libra M: microRNAs and thyroid
cancer: Biological and clinical significance (Review). Int J Mol
Med. 30:991–999. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Z, Sharp PP, Yao Y, Segal D, Ang CH,
Khaw SL, Aubrey BJ, Gong J, Kelly GL, Herold MJ, et al: BET
inhibition represses miR17-92 to drive BIM-initiated apoptosis of
normal and transformed hematopoietic cells. Leukemia. 30:1531–1541.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Forte S, La Rosa C, Pecce V, Rosignolo F
and Memeo L: The role of microRNAs in thyroid carcinomas.
Anticancer Res. 35:2037–2047. 2015.PubMed/NCBI
|
|
28
|
Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang
Z, Wang X, Lin Y, Mao Y, et al: Downregulation of microRNA-182-5p
contributes to renal cell carcinoma proliferation via activating
the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu N, Cui R-X, Sun Y, Guo R, Mao YP, Tang
LL, Jiang W, Liu X, Cheng YK, He QM, et al: A four-miRNA signature
identified from genome-wide serum miRNA profiling predicts survival
in patients with nasopharyngeal carcinoma. Int J Cancer.
134:1359–1368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sosonkina N, Starenki D and Park J-I: The
Role of STAT3 in Thyroid Cancer. Cancers (Basel). 6:526–544. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frank DA: STAT3 as a central mediator of
neoplastic cellular transformation. Cancer Lett. 251:199–210. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sansone P and Bromberg J: Targeting the
interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol.
30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chowdhari S and Saini N: Gene expression
profiling reveals the role of RIG1 like receptor signaling in p53
dependent apoptosis induced by PUVA in keratinocytes. Cell Signal.
28:25–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin H-P, Lin C-Y, Huo C, Hsiao PH, Su LC,
Jiang SS, Chan TM, Chang CH, Chen LT, Kung HJ, et al: Caffeic acid
phenethyl ester induced cell cycle arrest and growth inhibition in
androgen-independent prostate cancer cells via regulation of Skp2,
p53, p21Cip1 and p27Kip1. Oncotarget. 6:6684–6707. 2015. View Article : Google Scholar : PubMed/NCBI
|
